Windtree Therapeutics, Inc.
WINT
$0.5414
-$0.0267-4.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.82M | 1.73M | 2.77M | 1.59M | 2.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.09M | 3.92M | 4.74M | 11.45M | 4.41M |
| Operating Income | -4.09M | -3.92M | -4.74M | -11.45M | -4.41M |
| Income Before Tax | -4.05M | 2.69M | -2.99M | -11.83M | 10.33M |
| Income Tax Expenses | -- | -77.00K | -240.00K | 197.00K | 114.00K |
| Earnings from Continuing Operations | -4.05M | 2.77M | -2.75M | -12.02M | 10.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.05M | 2.77M | -2.75M | -12.02M | 10.22M |
| EBIT | -4.09M | -3.92M | -4.74M | -11.45M | -4.41M |
| EBITDA | -4.07M | -3.90M | -4.69M | -11.37M | -4.38M |
| EPS Basic | -4.63 | 0.40 | -211.39 | -1.05K | -- |
| Normalized Basic EPS | -2.31 | 16.24 | -107.81 | -642.77 | -- |
| EPS Diluted | -4.63 | 0.40 | -211.39 | -1.05K | -- |
| Normalized Diluted EPS | -2.31 | 16.24 | -107.81 | -642.77 | -- |
| Average Basic Shares Outstanding | 1.09M | 171.80K | 17.70K | 11.50K | -- |
| Average Diluted Shares Outstanding | 1.09M | 171.80K | 17.70K | 11.50K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.22% | 11.20% | -12.62% | -- | -- |